Provided by Tiger Trade Technology Pte. Ltd.

Biogen

220.77
+2.651.21%
Post-market: 220.770.00000.00%19:36 EDT
Volume:495.44K
Turnover:109.45M
Market Cap:32.59B
PE:39.21
High:222.85
Open:218.93
Low:218.00
Close:218.12
52wk High:222.85
52wk Low:131.52
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.66
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.73
PE(LYR):25.12

Loading ...

Biogen Q2 Revenue USD 2,700 Million VS. Ibes Estimate USD 2,458 Million

THOMSON REUTERS
·
Jul 29

Biogen Cuts FY Adjusted View as 2Q Profit Declines

Dow Jones
·
Jul 29

Biogen Raises Earnings Guidance as Growth Portfolio Outpaces Legacy Blockbuster Drugs

Dow Jones
·
Jul 29

Biogen Q2 FY26 GAAP Diluted EPS Drops 85% to $0.66; Revenue Rises 3% to $2.74 Billion

Reuters
·
Jul 29

Biogen Q2 Leqembi Global in-Market Sales $184 Mln, up 15% YoY

THOMSON REUTERS
·
Jul 29

Biogen: Conversion to High-Dose Spinraza Regimen Ahead of Co's Expectations in All Launched Geographies

THOMSON REUTERS
·
Jul 29

Biogen Outlook FY REV Expected to Increase by Mid-Single Digit Percentage

THOMSON REUTERS
·
Jul 29

Biogen Q2 REV $2.74 Bln vs Ibes Estimate $2.46 Bln

THOMSON REUTERS
·
Jul 29

Biogen Outlook Expected Dilution from Apellis Deal on FY Adj EPS $-0.85

THOMSON REUTERS
·
Jul 29

Biogen price target raised to $200 from $185 at Barclays

TIPRANKS
·
Jul 29

Biogen beats estimates as new medicines overtake multiple sclerosis business

Robert Langreth / Bloomberg
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Barclays Adjusts Biogen Price Target to $200 From $185, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28

Biogen Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28

Biogen’s BIIB144 First‑in‑Human Trial: What Early Safety Data Could Mean for BIIB Investors

TIPRANKS
·
Jul 28

Rothschild & Co Redburn Adjusts Price Target on Biogen to $210 From $190, Maintains Neutral Rating

MT Newswires Live
·
Jul 24

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 24

Earning Preview: Biogen Q2 revenue is expected to increase by 5.80%, majority of institutions hold constructive views

Earnings Agent
·
Jul 22

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 22